Nurix Therapeutics, Inc. (NRIX)
25.91
+0.13
(+0.50%)
USD |
NASDAQ |
Sep 01, 15:42
Nurix Therapeutics Cash and Short Term Investments (Quarterly) : 443.53M for May 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 443.53M |
| February 28, 2026 | 540.73M |
| November 30, 2025 | 592.94M |
| August 31, 2025 | 428.83M |
| May 31, 2025 | 485.78M |
| February 28, 2025 | 549.68M |
| November 30, 2024 | 609.58M |
| August 31, 2024 | 448.05M |
| May 31, 2024 | 443.14M |
| February 29, 2024 | 243.99M |
| November 30, 2023 | 287.91M |
| August 31, 2023 | 258.85M |
| May 31, 2023 | 281.18M |
| February 28, 2023 | 277.15M |
| Date | Value |
|---|---|
| November 30, 2022 | 309.14M |
| August 31, 2022 | 344.48M |
| May 31, 2022 | 297.28M |
| February 28, 2022 | 261.98M |
| November 30, 2021 | 295.72M |
| August 31, 2021 | 343.90M |
| May 31, 2021 | 386.02M |
| February 28, 2021 | 303.07M |
| November 30, 2020 | 281.15M |
| August 31, 2020 | 354.24M |
| May 31, 2020 | 173.50M |
| February 29, 2020 | 71.35M |
| November 30, 2019 | 37.72M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | 621.10M |
| Gilead Sciences, Inc. | 4.882B |
| TG Therapeutics, Inc. | 552.25M |
| Cue Biopharma, Inc. | 17.39M |
| Keros Therapeutics, Inc. | 257.61M |